March 4, 2019 – The Heart Rhythm Society (HRS) submitted comments to the Agency for Healthcare Research and Quality’s (AHRQ) in response to the Agency’s Technology Assessment (TA) Program as it assesses the use of cardiac resynchronization therapy (CRT) in the Medicare population.

Topic

  • Coverage
  • Regulatory Agencies

Resource Type

  • Comment Letter